At Lenco, we value the opportunity to deliver reliable diagnostic testing services to our patients and physicians. To continue to provide the best results, Lenco Diagnostic Laboratories has entered into a definitive agreement to sell select assets to Quest Diagnostics, the world’s leading provider of diagnostic information services. As part of the acquisition, which we expect will be complete in the first quarter of 2024, laboratory volumes will transition over time to Quest’s full-service laboratory in nearby Clifton, NJ.

What changes should I anticipate as a patient?

To provide lab testing continuity, Quest representatives are working collaboratively with your physicians to point new laboratory testing orders over to Quest effective as of the closing of the transaction. At that time, we expect:

• Patients will benefit from broader access to Quest’s innovative, industry-leading test menu and extensive patient service center network. Appointments can be prescheduled online at https://appointment.questdiagnostics.com/as-home
• Results for any Quest performed test will be available through Quest’s MyQuest app https://myquest.questdiagnostics.com/web/home and through your normal testing result channels at your doctor’s office instead of Lenco Link.
• Patients will also benefit from Quest’s expansive in-network health plan relationships including with Cigna, Blue Cross Commercial, Emblem Health and Metro Plus. Visit us at https://insurance.questdiagnostics.com
• Patient responsibility invoices will be sent from Quest for work performed by Quest. https://billing.questdiagnostics.com/PatientBilling

It has been a pleasure to serve you, and we look forward to continuing to provide access to laboratory testing to you through this new relationship with Quest. Thank-you!